Memory Pharmaceuticals' Unattributed VC Round

Memory Pharmaceuticals raised a round of funding on March 19, 2002.

Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…

Articles about Memory Pharmaceuticals' Unattributed VC Round: